Ítem


Hipertensión arterial y enfermedad de Alzheimer

Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studies

© Alzheimer. Realidades e investigación en demencia, 2010, núm. 45, p. 30-39

Editorial Glosa

Autor: Coll de Tuero, Gabriel
Data: 2010
Resum: Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studies
Format: application/pdf
ISSN: 1137-1242
Accés al document: http://hdl.handle.net/10256/7541
Llenguatge: eng
Editor: Editorial Glosa
Col·lecció: Articles publicats (D-CM)
És part de: © Alzheimer. Realidades e investigación en demencia, 2010, núm. 45, p. 30-39
Drets: Tots els drets reservats
Matèria: Hipertensió
Hypertension
Alzheimer, Malaltia d’ -- Tractament
Alzheimer’s disease -- Treatment
Títol: Hipertensión arterial y enfermedad de Alzheimer
Tipus: info:eu-repo/semantics/article
Repositori: DUGiDocs

Matèries

Autors